Elon Musk’s Neuralink files to trademark ‘Blindsight,’ ‘Telepathy,’ and ‘Telekinesis’

The article discusses how Elon Musk’s Neuralink has applied to trademark terms like “Telepathy,” “Blindsight,” and “Telekinesis” with the USPTO. These trademarks are related to Neuralink’s brain-computer interface products that aim to allow users to control devices with their thoughts and restore vision in blind individuals. Neuralink’s PRIME study has shown promising results with participants using the brain implants effectively in their daily lives.

Highlights:
1. Neuralink’s trademark applications for terms like “Telepathy” and “Blindsight” indicate the company’s focus on developing innovative brain-computer interface products.
2. The PRIME study by Neuralink has successfully implanted brain-computer interfaces in participants, allowing them to use devices hands-free and restore vision in blind individuals.
3. Neuralink’s experimental implant Blindsight has received FDA breakthrough device designation, showing recognition for its potential to improve the lives of visually impaired individuals.

In summary, the article highlights Neuralink’s advancements in developing brain-computer interface technology, including trademark applications for key terms and successful outcomes from their PRIME study to enhance human capabilities and improve quality of life for individuals with disabilities.

Editorial content by NewsSIP AI